Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no clinical evidence that Mounjaro (tirzepatide) and botox interfere with each other. The two treatments work on entirely different systems in the body — one is an injectable weight-loss medicine, the other a muscle-relaxing cosmetic procedure — and no UK regulatory guidance restricts combining them. That said, timing and your overall health picture matter, and your prescriber should know about all treatments you are having. Mounjaro is a prescription-only medicine; whether it is right for you is a clinical decision, not a self-assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common concern circulating online is that tirzepatide somehow interferes with how botulinum toxin takes effect, or that botox injections are unsafe while on weight-loss treatment. There is no pharmacological basis for this. Tirzepatide acts on GIP and GLP-1 receptors in the gut, pancreas and brain to reduce appetite and slow gastric emptying, as described on the tirzepatide overview. Botulinum toxin, meanwhile, works at the neuromuscular junction in local tissue, far removed from either receptor pathway. The two have no shared mechanism, no shared metabolism and no documented interaction in UK clinical guidance.
If you have read that you need to stop Mounjaro before a botox appointment, that advice almost certainly comes from an aesthetic practitioner who was being cautious about general anaesthetic protocols (which involve separate considerations) or from forums where anecdote travels faster than evidence. Caution is not always wrong, but it should be grounded in something real. This particular restriction is not.
That said, two things are still worth doing: tell both your prescribing clinician and your aesthetic practitioner that you are having both treatments. Transparency is not about danger, it is about giving practitioners the full picture so they can give you their best advice.
Even if there is no drug interaction, there is a practical consideration that is easy to overlook. Mounjaro's early weeks commonly bring nausea, fatigue or general GI discomfort, particularly when the dose increases. For some people this settles within days; for others it lingers into the second or third week of a new dose. Booking an elective cosmetic appointment in that window is not a safety issue, but it may simply not be the most comfortable experience.
A more practical approach is to time botox appointments during a settled period between dose changes, when you are feeling well. Most people find a comfortable groove with tirzepatide once they are established on a dose, and that is the sensible window for anything elective. There is a fuller discussion of what happens around dose changes on the botox on Mounjaro page, which goes into the specific practitioner-guidance angle in more detail.
One more consideration: if you are losing weight at a meaningful rate, facial volume can change over weeks and months. Some people find that aesthetic results they were used to (how their face responds to botox, for instance) feel different as their weight changes. This is worth factoring into treatment planning with your aesthetic practitioner, not as a contraindication but as a practical heads-up.
This is the part most people skip, and it is arguably the most useful. Your Mounjaro prescriber needs to know you are having botox because, taken in context, it gives a more accurate picture of your health and any elective procedures in your schedule. Equally, your aesthetic practitioner should know you are taking a prescription weight-loss medicine, both because responsible practitioners document all concurrent treatments and because it may affect their advice on timing.
There is some discussion online, and a separate detailed page about how Mounjaro affects botox, covering questions about absorption, swelling and post-procedure recovery in more detail. The short version: no evidence suggests botulinum toxin distributes differently in people taking tirzepatide. The longer version acknowledges that very few formal studies have looked at this combination specifically, which is why practitioner communication matters more than a blanket reassurance.
If you are considering starting Mounjaro and are a regular botox user, the combination is not a reason to hold back from exploring treatment. The Mounjaro treatment page outlines how the clinical consultation works at nume, and the information about weight-loss treatment options covers the full picture of what the assessment involves. As with every aspect of Mounjaro, the prescriber's role is to look at the whole person, not just one medicine in isolation.
On the cost side, it is worth knowing that legitimate Mounjaro treatment through a regulated online pharmacy includes the clinical consultation, prescription and aftercare in one price, nothing is itemised out. If you want to understand how private treatment is structured and what to watch out for, the weight-loss overview covers that context clearly. The about us page explains how nume operates as a GPhC-registered pharmacy, verifiable at the GPhC register.
People also ask about other combination questions when they are researching tirzepatide alongside other treatments. Questions like Lemon Bottle and Mounjaro or Mounjaro and erectile dysfunction come up regularly, and the pattern is similar: the absence of a known interaction is not the same as a green light to ignore communication between practitioners. Always keep the whole team informed. The FAQs address a wide range of these real-world combination questions if you want to read further before your consultation. The NHS's guidance on tirzepatide at nhs.uk is also worth bookmarking as the authoritative patient-level reference. For reporting any unexpected reactions to either treatment, the MHRA's Yellow Card scheme is the right route.
If you are weighing up whether to start Mounjaro, a free consultation with our prescribers is the right next step. Start your free consultation on the treatment page, a real clinician reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.